These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 16294508)

  • 1. [Anti-hormone breast cancer treatment. Convincing trials do exist--we have to take up a stand now!].
    Holmberg SB
    Lakartidningen; 2005 Oct 10-16; 102(41):2920-1. PubMed ID: 16294508
    [No Abstract]   [Full Text] [Related]  

  • 2. [Aromatase inhibitors for metastasing breast cancer in postmenopausal women. A survey of a Cochrane review].
    Aziz M; Skougaard K; Kamby C; Nielsen DL
    Ugeskr Laeger; 2008 Jun; 170(25):2248-52. PubMed ID: 18565316
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical decision making in breast cancer: TAM and aromatase inhibitors for older patients -- a jungle?
    Biganzoli L; Licitra S; Claudino W; Pestrin M; Leo AD
    Eur J Cancer; 2007 Oct; 43(15):2270-8. PubMed ID: 17698345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant therapy with aromatase inhibitors for postmenopausal women with early breast cancer: evidence and ongoing controversy.
    Wheler J; Johnson M; Seidman A
    Semin Oncol; 2006 Dec; 33(6):672-80. PubMed ID: 17145347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aromatase inhibitors in breast cancer: an overview.
    Altundag K; Ibrahim NK
    Oncologist; 2006 Jun; 11(6):553-62. PubMed ID: 16794235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hormonal therapy in breast cancer].
    Espinós J; Reyna C; de la Cruz S; Oiler C; Hernández A; Fernández Hidalgo O; Santisteban M; García Foncillas J
    Rev Med Univ Navarra; 2008; 52(1):40-8. PubMed ID: 18578196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aromatase inhibitors for the treatment of breast cancer: is tamoxifen of historical interest only?
    Van Poznak CH; Hayes DF
    J Natl Cancer Inst; 2006 Sep; 98(18):1261-3. PubMed ID: 16985239
    [No Abstract]   [Full Text] [Related]  

  • 8. Hormonal therapy for advanced breast cancer.
    Rugo HS
    Hematol Oncol Clin North Am; 2007 Apr; 21(2):273-91. PubMed ID: 17512449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aromatase inhibitors for early breast cancer therapy: a choice of effective treatment strategies.
    Dixon JM; Bundred N
    Eur J Surg Oncol; 2006 Mar; 32(2):123-5. PubMed ID: 16380226
    [No Abstract]   [Full Text] [Related]  

  • 10. [Adjuvant antihormonal therapy for postmenopausal women with primary operable breast cancer].
    Tuxen MK; Nielsen DL; Lindberg H; Kamby C
    Ugeskr Laeger; 2007 Jan; 169(4):297-9. PubMed ID: 17274922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aromatase inhibitors and breast cancer.
    Miller WR
    Minerva Endocrinol; 2006 Mar; 31(1):27-46. PubMed ID: 16498362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival with aromatase inhibitors and inactivators versus standard hormonal therapy in advanced breast cancer: meta-analysis.
    Mauri D; Pavlidis N; Polyzos NP; Ioannidis JP
    J Natl Cancer Inst; 2006 Sep; 98(18):1285-91. PubMed ID: 16985247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospects of neoadjuvant aromatase inhibitor therapy in breast cancer.
    Dixon JM
    Expert Rev Anticancer Ther; 2008 Mar; 8(3):453-63. PubMed ID: 18366292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent topics in endocrine therapy for hormone-dependent breast cancer: basic research and clinical applications.
    Kimijima I
    Breast Cancer; 2008; 15(4):253-5. PubMed ID: 18953680
    [No Abstract]   [Full Text] [Related]  

  • 15. The evolving role of aromatase inhibitors in the treatment of early-stage breast cancer.
    Ryan PD; Goss PE
    Nat Clin Pract Oncol; 2005 Dec; 2(12):596-7. PubMed ID: 16341095
    [No Abstract]   [Full Text] [Related]  

  • 16. Aromatase inhibitors--socio-economical issues.
    Lønning PE; Geisler J
    J Steroid Biochem Mol Biol; 2005 May; 95(1-5):137-42. PubMed ID: 15955693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progression of endocrine therapies for breast cancer: where are we headed?
    Arnedos M; Smith I
    Expert Rev Anticancer Ther; 2007 Nov; 7(11):1651-64. PubMed ID: 18020931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adherence to endocrine therapy for breast cancer.
    Chlebowski RT; Geller ML
    Oncology; 2006; 71(1-2):1-9. PubMed ID: 17344666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aromatase inhibitors as adjuvant treatment of breast cancer.
    Geisler J; Lønning PE
    Crit Rev Oncol Hematol; 2006 Jan; 57(1):53-61. PubMed ID: 16337805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SERMs: meeting the promise of multifunctional medicines.
    Jordan VC
    J Natl Cancer Inst; 2007 Mar; 99(5):350-6. PubMed ID: 17341726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.